# HPV Vaccine Reduced Dose

> **NCT06799494** · PHASE4 · RECRUITING · sponsor: **Emory University** · enrollment: 100 (estimated)

## Conditions studied

- HPV

## Interventions

- **BIOLOGICAL:** Gardasil-9
- **DRUG:** Lidocaine injection
- **DRUG:** Lorazepam

## Key facts

- **NCT ID:** NCT06799494
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-06
- **Primary completion:** 2028-09
- **Final completion:** 2028-09
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-08-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06799494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06799494, "HPV Vaccine Reduced Dose". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06799494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*